Silence Therapeutics (SLN) Q3 2024 Earnings

Aug 15Confirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.18
-0.12
-0.06
0

Details

Expected EPS
-0.0375813175
Actual EPS
-0.0467791
Surprise EPS
-0.01
Surprise Percent
-24.47%

Description

⁨Silence Therapeutics⁩ (⁦SLN⁩) has reported earnings of ⁦-0.0467791⁩ per share for ⁦Q3 2024⁩.

0 Comments

Share your thoughts